ArticleJournal of cardiovascular and thoracic research2020
Agreement between Framingham, IraPEN and non-laboratory WHO-EMR risk score calculators for cardiovascular risk prediction in a large Iranian population.
Article in Journal of cardiovascular and thoracic research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Comparison of FINDRISC and the Framingham Model for Predicting CHD Risk: Results from the Kharameh Cohort Study.Vascular health and risk management · 2026Article
- Using implementation science for WHO noncommunicable disease technical packages in low-and middle-income countries: a scoping review.Frontiers in health services · 2026Review
- Evaluating Cardiovascular Risk Factors Among Healthcare Professionals in Iran.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Atherosclerotic cardiovascular disease risk among Ghanaians: A comparison of the risk assessment tools.American journal of preventive cardiology · 2024Article
- Biomedical Big Data Technologies, Applications, and Challenges for Precision Medicine: A Review.Global challenges (Hoboken, NJ) · 2024Review
- Risk estimation of cardiovascular diseases using the World Health Organization/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study.Journal of cardiovascular and thoracic research · 2024Article
- A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study.Journal of translational medicine · 2023Article
- Article
- Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran.BMC cardiovascular disorders · 2023Article
- Illness perception and cardiovascular risk factors in patients with myocardial infarction undergoing percutaneous coronary intervention in Iran.BMC cardiovascular disorders · 2022Article
- Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran.Scientific reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.